Risk-stratified outcomes of nonmyeloablative HLA-haploidentical BMT with high-dose posttransplantation cyclophosphamideShannon R. McCurdy, Yvette L. Kasamon, Heather J. Symons et al.|Blood|2015Cited by 299
Comparable composite endpoints after HLA-matched and HLA-haploidentical transplantation with post-transplantation cyclophosphamideShannon R. McCurdy, Leo Luznik, Yvette L. Kasamon et al.|Haematologica|2016Cited by 187
Outcomes of Related Donor HLA-Identical or HLA-Haploidentical Allogeneic Blood or Marrow Transplantation for Peripheral T Cell LymphomaJennifer A. Kanakry, Richard F. Ambinder, Yvette L. Kasamon et al.|Biology of Blood and Marrow Transplantation|2013Cited by 88
Early Fever after Haploidentical Bone Marrow Transplantation Correlates with Class II HLA-Mismatching and Myeloablation but Not OutcomesShannon R. McCurdy, Ephraim J. Fuchs, Stephen Muth et al.|Biology of Blood and Marrow Transplantation|2018Cited by 41